Clinical Trial Update: S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract [Phase 2]

View source ↗

Summary

Phase 2 SWOG trial of gemcitabine and paclitaxel in advanced or recurrent urinary tract cancers (bladder cancer, transitional cell carcinoma of the renal pelvis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter
• Urethral Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: TERMINATED | Results posted: 2016-02-24